EPISODE · Sep 25, 2025 · 17 MIN
Results of ATTAIN-1 and STEP UP Phase 3 Trials
from Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives · host Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospital Diabetes and Metabolic Care Center, discuss the recently published results of the ATTAIN-1 and STEP UP clinical trials, both of which were presented at the European Association for the Study of Diabetes (EASD) 2025 Conference.00:00:00 Introduction00:00:32 ATTAIN-100:04:07 GLP-1s as a Daily Pill00:08:20 Possible Lower GLP-1 Prices00:09:03 STEP UP00:11:41 Cardiovascular Protection with GLP-1s00:12:48 GI Side Effects of Semaglutide 7.200:16:16 3 Times the Dose, 3 Times the Cardiovascular Protection?00:17:20 Outro
Embed this episode
NOW PLAYING
Results of ATTAIN-1 and STEP UP Phase 3 Trials
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.